B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma

B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma

Background: B4GALT5 is postulated to be an important protein in sugar metabolism that catalyzes the synthesis of lactosylceramide (LacCer). However, its role in hepatocellular carcinoma (HCC) remains unknown. Method: We characterized the expression of B4GALT5 in HCC tissue compared to normal tissue,...

Full description

Bibliographic Details
Main Authors:	Han, Y. (Author), Li, Z. (Author), Liu, H. (Author), Luo, J. (Author), Sun, Z. (Author), Wu, Q. (Author), Wu, Y. (Author)
Format:	Article
Language:	English
Published:	BioMed Central Ltd 2022
Subjects:	Biomarkers, Tumor Carcinoma, Hepatocellular Expression level Hepatocellular carcinoma human Humans Immune infiltration level liver cell carcinoma Liver Neoplasms liver tumor messenger RNA metabolism pathology prognosis Prognosis Prognostic biomarker RNA, Messenger Survival analysis tumor marker
Online Access:	View Fulltext in Publisher

Similar Items

A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells
by: Han, B., et al.
Published: (2022)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
by: Jurek-Loughrey, A., et al.
Published: (2021)

Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches
by: Huaping Chen, et al.
Published: (2021-01-01)

Hepatocellular carcinoma in Brazil: report of a national survey (Florianópolis, SC, 1995)
by: GONÇALVES Carlos S., et al.
Published: (1997-01-01)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
by: Lu Yin, et al.
Published: (2021-02-01)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
by: José D. Debes, et al.
Published: (2021-04-01)

Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
by: Shan-Shan Jiang, et al.
Published: (2021-03-01)

Mixed fibrolamellar hepatocellular carcinoma
by: Faten Limaiem, et al.
Published: (2021-06-01)

Molecular Associations and Clinical Significance of RAPs in Hepatocellular Carcinoma
by: Sarita Kumari, et al.
Published: (2021-06-01)

Hepatocellular carcinoma. An overview
by: Daniel Motola-Kuba, et al.
Published: (2006-01-01)

BUB1 predicts poor prognosis and immune status in liver hepatocellular carcinoma
by: Bai, Y., et al.
Published: (2022)

Serum agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
by: Hye Soo Kim, et al.
Published: (2020-01-01)

Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion
by: Wenwen Dou, et al.
Published: (2020-05-01)

Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
by: Kyuho Lee, et al.
Published: (2017-01-01)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
by: Shun-Jun Fu, et al.
Published: (2018-08-01)

Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis
by: Nanfang Qu, et al.
Published: (2020-02-01)

Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
by: Xingwei Xie, et al.
Published: (2021-03-01)

Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience
by: Wang P, et al.
Published: (2015-12-01)

Biomarkers for Locally Advanced Hepatocellular Carcinoma Patients Treated with Liver-Directed Combined Radiotherapy
by: Chung, S.Y, et al.
Published: (2022)

Using Hepatocellular Carcinoma Tumor Burden Score to Stratify Prognosis after Liver Transplantation
by: Dimitrios Moris, et al.
Published: (2020-11-01)

Production of monoclonal antibody specific to surface antigen on hepatocellular carcinoma cell lines
by: Pawaraid On-Tong, et al.
Published: (2011-01-01)

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates
by: Yuan Nie, et al.
Published: (2021-03-01)

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
by: Li L, et al.
Published: (2014-05-01)

Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances
by: Yucheng Zhang, et al.
Published: (2021-05-01)

Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma
by: Xiumei Wang, et al.
Published: (2018-11-01)

Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study
by: Chen H, et al.
Published: (2019-04-01)

Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients
by: Markus Bo Schoenberg, et al.
Published: (2018-10-01)

Systematic Analyses of the Role of the Reader Protein of N6-Methyladenosine RNA Methylation, YTH Domain Family 2, in Liver Hepatocellular Carcinoma
by: Xiang-yang Shao, et al.
Published: (2020-12-01)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
by: Shanshan Liu, et al.
Published: (2021-09-01)

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
by: Liao X, et al.
Published: (2018-04-01)

AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
by: Yan Liao, et al.
Published: (2021-02-01)

Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
by: Yi-hong Ling, et al.
Published: (2020-06-01)

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
by: Xing-Wei Xie, et al.
Published: (2021-01-01)

From a Philosophical Framework to a Valid Prognostic Staging System of the New “Comprehensive Assessment” for Transplantable Hepatocellular Carcinoma
by: Stefano Di Sandro, et al.
Published: (2019-05-01)

The role of circular RNA hsa_circ_0085616 in proliferation and migration of hepatocellular carcinoma cells
by: Li W, et al.
Published: (2019-08-01)

AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma
by: Chenxi Ma, et al.
Published: (2020-12-01)

A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular carcinoma based on the WGCNA hub-gene screening trategy
by: Guo, G., et al.
Published: (2022)

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
by: Chen H, et al.
Published: (2018-07-01)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
by: Bo Yang, et al.
Published: (2020-09-01)

Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
by: Qianhui Xu, et al.
Published: (2021-08-01)